Highlights: Novel 3D biology technology supported by a new €800,000 grant from the Austrian Research Promotion Agency (FFG) Investing to double R&D footprint in Salzburg, Austria Adding customer support roles in Italy, Spain, and Portugal San Jose, C alif.– Molecular Devices, LLC. , a leading provider of high-performance life science solutions, is expanding its R&D facility in […]
Improved access to induced pluripotent stem cells for allogeneic cell therapy applications SEATTLE — Pluristyx, Inc., an advanced therapy tools and services biotechnology company, panCELLa, a privately held biotechnology company, and Implant Therapeutics, a developer of genetically engineered stem cells, today announced they have entered into a manufacturing and distribution strategic alliance that offers cell […]
myCurio™ Accelerates Plant Genomics Research & Development ANN ARBOR, MICHIGAN, UNITED STATES — Curio Genomics and Daicel Arbor Biosciences announced the launch of the cloud-based bioinformatics platform myCurio™, resulting from their multi-year product development and marketing partnership. The integration of myCurio into Arbor’s industry-recognized myBaits™ and myReads™ custom NGS products and services provides unique and powerful […]
Collaboration will enable transparent, cGMP, and scalable manufacture of custom cell culture media Cytiva, a global life sciences leader, and Nucleus Biologics, LLC, The Cell Performance Company™, have signed a collaboration agreement on custom media formulation and fulfillment solutions for the cell and gene therapy industry. Utilizing Nucleus Biologics’ proprietary platform, Cytiva customers will have […]
Partnership will optimize manufacturing of extracellular vesicles (EVs) using scalable and continuous bioprocessing technologies to propel the commercialization of regenerative therapies at affordable costs. Proof-of-concept of exosomes manufacturing in scale-X™ bioreactor to demonstrate advantages of intensified and integrated platforms RoosterBio to leverage scalable, continuous bioprocessing technologies to deliver regenerative therapies at reduced timelines and costs, […]
Cytiva welcomes Nucleus Biologics’ proven and powerful AI-powered interface that brings state-of-the-art cell media design and supply to the Cell and Gene Therapy Industry. Cell and gene therapies are critically reliant on the growth and maintenance of a viable and efficacious cell population. It is proven that cell culture media can have a profound impact […]
Ms. Moy brings 30 years of HR leadership experience at high-performing companies MARLBOROUGH, Mass. — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the appointment of Marilee Moy as Chief People Officer. Ms. Moy has more than 30 years of HR leadership experience at high-performing life sciences and technology companies. She […]
Proof-of-concept of exosomes manufacturing in scale-X™ bioreactor to demonstrate advantages of intensified and integrated platforms. RoosterBio to leverage scalable, continuous bioprocessing technologies to deliver regenerative therapies at reduced timelines and costs, improving access for patients. FREDERICK, Md. — Univercells Technologies, a leading provider of novel biomanufacturing technologies for flexible and scalable viral production, announces today […]
Corning 3D solutions, including the company’s new Matribot® bioprinter, support life science innovation in areas including drug screening and precision medicine CORNING, N.Y. – Corning Incorporated will highlight its latest technologies that support the advancement of 3D cell culture and drug discovery at this year’s Society for Laboratory Automation and Screening (SLAS) conference in Boston […]
Monoclonal Antibodies for COVID-19 Omicron Variant Research AMSBIO has announced new additions to its portfolio of tools for COVID-19 research – two monoclonal antibodies that recognize the Spike RBD (B.1.1.529, Omicron Variant) protein and neutralizes its interaction with ACE2. The human ACE2 receptor is found on the surface of type I and II pneumocytes, endothelial cells, […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
